Ciccimaro Eugene, Hanks Steven K, Blair Ian A
Department of Pharmacology, Centers for Cancer Pharmacology and Excellence in Environmental Toxicology, University of Pennsylvania, Philadelphia, Pennsylvania 19104-6160, USA.
Mol Pharmacol. 2009 Mar;75(3):658-66. doi: 10.1124/mol.108.052464. Epub 2008 Dec 19.
A recently developed stable isotope dilution liquid chromatography-multiple reaction/mass spectrometry method to quantify focal adhesion kinase (FAK) activation loop phosphorylation was used to study endogenous Src kinase activity. This revealed that bis-phosphorylated pTyr(576)/Tyr(577)-FAK was a biomarker of Src activity and inactivation in vitro and in cell culture. Mouse embryonic fibroblasts (MEFs) expressing endogenous Src family kinases contained 65% unmodified Tyr(576)/Tyr(577), 33% mono-phosphorylated-pTyr(576)-FAK, and 6% bis-phosphorylated-pTyr(576)/pTyr(577)-FAK. In contrast, MEFs expressing oncogenic Y(529)FSrc contained 38% unmodified Tyr(576)/Tyr(577)-FAK, 29% mono-phosphorylated-pTyr(576)-FAK, and 19% bis-phosphorylated-pTyr(576)/pTyr(577)-FAK. This new method has made it possible to accurately determine the absolute amounts of FAK phosphorylation that occur after Src inhibition in cell culture and in vitro with increasing concentrations of the Src inhibitor N-(5-chloro-1,3-benzodioxol-4-yl)-7-[2-(4-methylpiperazin-1-yl)ethoxy]-5-(tetrahydro-2H-pyran-4-yloxy)quinazolin-4-amine (AZD0530). Phosphorylation of FAK at Tyr(576)/Tyr(577) was inhibited by AZD0530 in a dose-dependent manner both in cell culture and in vitro. However, there was a substantial difference in the ability of AZD0530 to inhibit Src that was constitutively activated in a cellular context (IC(50) = 2.12 muM) compared with the isolated enzyme (IC(50) = 0.14 muM). When normal MEFs and Y(529)FSrc-expressing MEFs were treated with pervanadate (a global phosphatase inhibitor), pTyr(576)/pTyr(577)-FAK accounted for almost 60% of the total FAK present in the cells. This suggests that activation loop phosphorylation is regulated by tyrosine phosphatases. These results confirm that FAK phosphorylation is a useful biomarker of Src inhibition in vivo. The accuracy and specificity of stable isotope dilution liquid chromatography-mass spectrometry methodology offers significant advantages over current immunochemical approaches for monitoring Src activity.
一种最近开发的用于定量粘着斑激酶(FAK)激活环磷酸化的稳定同位素稀释液相色谱 - 多反应/质谱方法被用于研究内源性Src激酶活性。这表明双磷酸化的pTyr(576)/Tyr(577)-FAK是体外和细胞培养中Src活性和失活的生物标志物。表达内源性Src家族激酶的小鼠胚胎成纤维细胞(MEF)含有65%未修饰的Tyr(576)/Tyr(577)、33%单磷酸化的pTyr(576)-FAK和6%双磷酸化的pTyr(576)/pTyr(577)-FAK。相比之下,表达致癌性Y(529)FSrc的MEF含有38%未修饰的Tyr(576)/Tyr(577)-FAK、29%单磷酸化的pTyr(576)-FAK和19%双磷酸化的pTyr(576)/pTyr(577)-FAK。这种新方法使得能够准确测定在细胞培养和体外随着Src抑制剂N-(5-氯-1,3-苯并二氧杂环戊烯-4-基)-7-[2-(4-甲基哌嗪-1-基)乙氧基]-5-(四氢-2H-吡喃-4-基氧基)喹唑啉-4-胺(AZD0530)浓度增加时Src抑制后FAK磷酸化的绝对量。在细胞培养和体外,AZD0530均以剂量依赖性方式抑制FAK在Tyr(576)/Tyr(577)处的磷酸化。然而,与分离的酶(IC(50)=0.14μM)相比,AZD0530抑制在细胞环境中组成性激活的Src的能力存在显著差异(IC(50)=2.12μM)。当用过钒酸盐(一种全局磷酸酶抑制剂)处理正常MEF和表达Y(529)FSrc的MEF时,pTyr(576)/pTyr(577)-FAK占细胞中总FAK的近60%。这表明激活环磷酸化受酪氨酸磷酸酶调节。这些结果证实FAK磷酸化是体内Src抑制的有用生物标志物。稳定同位素稀释液相色谱 - 质谱方法的准确性和特异性相对于目前用于监测Src活性的免疫化学方法具有显著优势。